P2481Impella assist device or intraaortic balloon pump for treatment of cardiogenic shock due to acute coronary syndrome
Brunilda Alushi(Deutsches Herzzentrum der Charité), Carsten Skurk(Universität Hamburg), Florian Krackhardt(Charité - Universitätsmedizin Berlin), Andel Douedari(Charité - Universitätsmedizin Berlin), Wulf Knie(Apple (Israel)), Ulf Landmesser(Deutsches Herzzentrum der Charité), G. Froehlich(Charité - Universitätsmedizin Berlin), H Mochmann(Charité - Universitätsmedizin Berlin), David M. Leistner(University of Salzburg), B E Staehli(University Hospital Zurich), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 1
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k